INDmoney
4d Molecular Therapeutics Inc Stock Performance
as on January 28, 2026 at 9:37 pm IST
Day's Low
Day's High
$8.29$8.82
3.15%
Downside
3.04%
Upside
52 Week's Low
52 Week's High
$2.24$12.3473.89%
Downside
44.16%
Upside
4d Molecular Therapeutics Inc share price movements today
- Previous Close
- $8.49
- Open
- $8.52
- Volume
- 220.9K
- Day's Low - High
- $8.29 - $8.82
- 52 Week Low - High
- $2.24 - $12.34
4d Molecular Therapeutics Inc Historical Returns
- 1 Month Return
- + 6.52 %
- 3 Month Return
- -29.07 %
- 1 Year Return
- + 82.58 %
- 3 Year Return
- -60.07 %
- 5 Year Return
- -79.79 %
4d Molecular Therapeutics Inc Stock Fundamentals & Key Indicators
Check 4d Molecular Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$455.4M
EPS (TTM)
-3.2586
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-7.21
Industry PE ratio
-1.8136016949152542
PEG Ratio
0EBITDA
-222.7M
Revenue (TTM)
120.0K
Profit Margin
0.00%
Return On Equity TTM
-45.38%
4d Molecular Therapeutics Inc Stock Valuation
Track how 4d Molecular Therapeutics Inc P/E has moved over time to understand its valuation trends.
4d Molecular Therapeutics Inc in the last 5 years
Lowest (-11.00x)
June 30, 2024
Today (-7.21x)
January 28, 2026
Industry (-1.81x)
January 28, 2026
Highest (-1.00x)
June 30, 2025
Today’s Price to Earnings Ratio: -7.21x
4d Molecular Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of 4d Molecular Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $455.4M | -79.79% | -7.21 | 0.00% | |
| BUY | $47.7B | 129.26% | 1246.03 | 1.36% | |
| BUY | $122.3B | 106.13% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 52.34% | 18.28 | 32.13% |
Stock Returns calculator for 4d Molecular Therapeutics Inc Stock including INR - Dollar returns
The 4d Molecular Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
4d Molecular Therapeutics Inc investment value today
Current value as on today
₹1,90,060
Returns
₹90,060
(+90.06%)
Returns from 4d Molecular Therapeutics Inc Stock
₹84,086 (+84.09%)
Dollar Returns*
₹5,974 (+5.97%)
Analyst Recommendation on 4d Molecular Therapeutics Inc Stock
Based on 17 analysts
94.12%
Buy
5.88%
Hold
0.00%
Sell
Based on 17 analysts, 94.12% of analysts recommend a 'BUY' rating for 4d Molecular Therapeutics Inc. Average target price of $33.11
4d Molecular Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on 4d Molecular Therapeutics Inc.
What analysts predicted
74.15%UPSIDE
Target Price
$33.11
Current Price
$8.56
Analyzed by
17 Analysts
Target
$33.11
4d Molecular Therapeutics Inc target price $33.11, a slight upside of 74.15% compared to current price of $8.56. According to 17 analysts rating.
4d Molecular Therapeutics Inc Stock’s Investor Sentiment and Interest
Search interest for 4d Molecular Therapeutics Inc Stock has decreased by -59% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
4d Molecular Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
4d Molecular Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
4d Molecular Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
4d Molecular Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Insights on 4d Molecular Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 4 quarters, 1.0K → 90.0K (in $), with an average increase of 61.0% per quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, FDMT stock has moved up by 10.4%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, FDMT has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 29.4% return, outperforming this stock by 89.5%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -47.97M → -56.87M (in $), with an average decrease of 9.0% per quarter
About 4d Molecular Therapeutics Inc
| Organisation | 4d Molecular Therapeutics Inc |
| Headquarters | 5858 Horton Street, EmeryVille, CA, United States, 94608 |
| Industry | Healthcare |
| CEO | Dr. David H. Kirn M.D. |
| E-voting on shares | Click here to vote |
Key Management of 4d Molecular Therapeutics Inc
Name | Title |
|---|---|
Dr. An Song Ph.D. | Chief Translational Medicine Advisor |
Dr. John F. Milligan Ph.D. | Executive Chairman |
Dr. Katy Barglow Ph.D. | Chief Technical Officer |
Ms. Theresa Janke | Co-Founder & Chief of Staff |
Mr. Kristian Humer M.B.A. | CFO & Principal Financial Officer |
Mr. Ashoo Gupta | Principal Accounting Officer & Principal Financial Officer |
Julian Pei | Head of Investor Relations & Corporate Finance |
Dr. Scott P. Bizily J.D., Ph.D. | Chief Legal Officer & Corporate Secretary |
Dr. David H. Kirn M.D. | Co-Founder, President, CEO & Director |
Dr. Fariborz Kamal Ph.D. | Chief Technical Advisor |
FAQs
What is 4d Molecular Therapeutics Inc share price today?
4d Molecular Therapeutics Inc share price today is $8.56 as on . 4d Molecular Therapeutics Inc share today touched a day high of $8.82 and a low of $8.29.
What is the 52 week high and 52 week low for 4d Molecular Therapeutics Inc share?
4d Molecular Therapeutics Inc share touched a 52 week high of $12.34 on and a 52 week low of $2.24 on . 4d Molecular Therapeutics Inc stock price today i.e. is trending at $8.56,which is 30.63% down from its 52 week high and 283.00% up from its 52 week low.
What is 4d Molecular Therapeutics Inc's market capitalisation today?
4d Molecular Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in 4d Molecular Therapeutics Inc Stock (FDMT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for 4d Molecular Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in 4d Molecular Therapeutics Inc Shares that will get you 0.1752 shares as per 4d Molecular Therapeutics Inc share price of $8.56 per share as on January 28, 2026 at 9:37 pm IST.
What is the minimum amount required to buy 4d Molecular Therapeutics Inc Stock (FDMT) from India?
Indian investors can start investing in 4d Molecular Therapeutics Inc (FDMT) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in 4d Molecular Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on 4d Molecular Therapeutics Inc share’s latest price of $8.56 as on January 28, 2026 at 9:37 pm IST, you will get 1.1682 shares of 4d Molecular Therapeutics Inc. Learn more about
fractional shares .
What are the returns that 4d Molecular Therapeutics Inc has given to Indian investors in the last 5 years?
4d Molecular Therapeutics Inc stock has given -79.79% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?